[Difficult diagnosis in a 17-year-old patient: Type 1 diabetes? Type 2 diabetes? Or "double diabetes"?]

Dtsch Med Wochenschr. 2014 May;139(21):1097-9. doi: 10.1055/s-0034-1369979. Epub 2014 May 13.
[Article in German]

Abstract

MEDICAL HISTORY AND CLINICAL FINDINGS: We report on a 17-year-old boy with elevated blood glucose levels, elevated liver enzymes and obesity (BMI 32.3 kg/m2). Clinical examination showed acanthosis nigricans and a vitiligo. The rest of the physical examination was without pathological findings.

Investigations: The HbA1c value was 8.6 % (71 mmol/mol), and postprandial C-peptide showed a maximum level of 1.3 nmol/l. The type 1 diabetes-associated autoantibodies against protein tyrosine phosphatase IA-2 and zinc-transporter-8 were positive, while autoantibodies to glutamic acid decarboxylase and insulin were negative. There was no ketonuria. Ultrasound showed steatohepatitis.

Treatment and course: Under therapy with metformin up to 2×1 g, blood glucose levels and liver enzymes normalized after a few weeks. After two months, the HbA1c value was 6.0 % (42.1 mmol/mol), and a weight loss of 5 kg was recorded.

Conclusion: In obese adolescent patients with diabetes, a clear classification right from the beginning is not always possible. Characteristic findings of type 1 and type 2 diabetes may be present simultaneously. In the presented patient, monotherapy with metformin was sufficient in the first year. Close monitoring is essential to detect the transition to insulin dependence in time.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Autoantibodies / blood
  • Blood Glucose / metabolism
  • C-Peptide / blood
  • Cation Transport Proteins / immunology
  • Comorbidity
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / diagnosis*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diagnosis, Differential
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Metformin / therapeutic use
  • Pediatric Obesity / blood
  • Pediatric Obesity / complications
  • Receptor-Like Protein Tyrosine Phosphatases, Class 8 / immunology
  • Zinc Transporter 8

Substances

  • Autoantibodies
  • Blood Glucose
  • C-Peptide
  • Cation Transport Proteins
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • SLC30A8 protein, human
  • Zinc Transporter 8
  • hemoglobin A1c protein, human
  • Metformin
  • Receptor-Like Protein Tyrosine Phosphatases, Class 8